Indraprastha Medical Corporation Limited — Others, 09-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Indraprastha Medical Corporation Limited has announced a board meeting on 9th April, 2025, to discuss the financial results for the quarter and half-year ended 31st March, 2025. The company has received a confirmation certificate regarding the dematerialization of securities during the quarter, ensuring compliance with SEBI regulations. This certificate verifies that the securities related to the dematerialization process were duly accepted or rejected by the depositories.

This update reinforces the company’s operational integrity in capital management, which is likely to bolster investor confidence. The announcement suggests a stable operational framework and a proactive approach to regulatory compliance. Investors may view this positively, indicating manageable operational risks and a commitment to transparency in corporate governance.